# Final 10/10 Thesis Quality Review

**Date:** 2026-05-25  
**Official Persian title:** فیوشات درمانی: پیش‌بینی هوشمند قابلیت درمان با توکن‌های علائم از داده‌های تجمیع‌شده  
**Canonical metrics source:** `results/CANONICAL_METRICS.json`  

## 1. What Was Improved

- Added and propagated a clear operational definition of treatment feasibility: prediction of a measurable ICU outcome from early clinical signals, not autonomous treatment recommendation, automated prescription, or replacement of physician judgment.
- Strengthened the scientific story so the thesis is framed as a rigorous feasibility investigation of few-shot, federated, ETHOS-inspired representation learning, symptom tokenization, and hybrid modeling under limited/privacy-sensitive clinical data.
- Reworked Persian academic phrasing in the abstract, introduction, proposal-alignment section, methods, results, discussion, conclusion, preface, and defense notes to sound more natural, formal, and defensible.
- Standardized high-risk terminology: `یادگیری کم‌نمونه`, `توکن‌های علائم`, `توکن‌سازی علائم`, `رمزگذار ETHOS`, `بردار نهفته/نهفته‌سازی`, `Random Forest`, `AUROC`, `F1`, and `Stacked BEST`.
- Clarified the protocol-specific relationship between `0.762` RandomForest in Exp1 and `0.748` frozen Tabular SOTA so they are not read as contradictory.
- Polished the final defense slides by using short Beamer metadata for the footer while preserving the full title on the title slide, and added the explicit boundary that the model is not a replacement for physician judgment.

## 2. Proposal Alignment Status

The proposal’s core components are now explicitly mapped to the final thesis:

- Few-Shot Learning: fully covered through episodic/prototypical few-shot experiments and stacked few-shot pipelines.
- Federated Learning: partially covered through disease-node FedAvg simulation; real multisite deployment remains future work.
- ETHOS and Symptom Tokens: fully covered as the representation-learning branch.
- Aggregated/multisource healthcare data: scoped to MIMIC-IV ICU labs, vitals, demographics, engineered features, and disease nodes.
- Treatment feasibility prediction: fully covered as an operational measurable ICU outcome proxy.
- Wearable streams, production UI, and real multicenter deployment: honestly documented as future work due to access/time limits in an MSc project.

## 3. Scientific Claim Audit

- Metrics were not changed.
- The thesis no longer implies that raw few-shot beats classical ML.
- The negative/mixed result is explicit: raw few-shot underperforms RandomForest under Exp1.
- The contribution is framed as hybrid/stacked clinical AI feasibility, not a clinical-ready treatment recommender.
- Privacy claims are limited to simulation/deployment value; the thesis does not claim guaranteed privacy beyond the simulated federated setup.
- Statistical comparisons are now described carefully where paired prediction vectors are not available.

## 4. Terminology Fixes

- Replaced inconsistent few-shot Persian phrasing with `یادگیری کم‌نمونه` in visible thesis/defense sections.
- Replaced remaining `توکن علامت/توکن‌های علامت` forms with `توکن‌های علائم`.
- Replaced high-visibility `جاسازی` terminology with `بردار نهفته`, `فضای نهفته`, or `نهفته‌سازی`.
- Corrected the AUROC explanation: AUROC is threshold-independent; F1 is threshold-dependent.
- Softened overstrong phrases such as “first” or statistical equality where the evidence is descriptive rather than formally paired.

## 5. Treatment Feasibility Definition

The thesis now consistently states:

> در این پژوهش، قابلیت/امکان‌پذیری درمان به‌صورت عملیاتی به‌معنای پیش‌بینی یک پیامد بالینی قابل‌اندازه‌گیری بر اساس سیگنال‌های اولیه بیمار در ICU تعریف می‌شود. این مفهوم به‌معنای توصیه مستقیم درمان، نسخه‌نویسی خودکار یا جایگزینی تصمیم پزشک نیست.

This clarification appears in the Persian abstract, introduction, discussion, conclusion, README, and defense materials.

## 6. Results Narrative Status

The final narrative is now defensible:

- Tabular SOTA is strong: AUROC `0.748`.
- Exp1 RandomForest is stronger than raw Proposed_FewShot: `0.762` vs `0.611`.
- FewShot BEST alone reaches `0.670`, which is not enough to replace classical ML.
- Stacked BEST reaches `0.746` and descriptively closes most of the gap to the tabular ceiling.
- Federated simulation has a small AUROC cost of about `0.005`, supporting privacy-aware deployment value while not claiming clinical deployment readiness.

## 7. Statistical Limitation Status

The thesis now states that formal paired statistical comparison is limited when models do not produce aligned prediction vectors under identical protocols. It recommends paired bootstrap, DeLong, McNemar, calibration comparison, and external validation as future work.

## 8. PDF / RTL Polish Status

- XePersian build passes.
- Missing-character warnings are zero.
- Undefined citations are zero.
- Undefined references are zero.
- Persian/English/code terms are typeset safely in the main thesis build.
- Remaining overfull/underfull boxes are cosmetic and within the validator’s tolerance for this XePersian RTL thesis.
- Targeted visual inspection was performed on the cover, table of contents, introduction pages, method/results pages, English abstract, and defense slide title/results pages.

## 9. Remaining Minor Risks

- MIMIC-IV is single-center; no external validation is included.
- The cohort is a 2,000-patient research subset, not the full MIMIC-IV population.
- Treatment feasibility is a proxy label based on discharge/readmission logic.
- Federated learning is simulated by disease nodes, not deployed across real hospitals.
- Wearable data, live UI, and prospective clinical deployment remain future work.

## 10. Final Readiness Score

| Area | Score |
|------|------:|
| Scientific honesty | 9.8/10 |
| Proposal alignment | 9.8/10 |
| Persian academic writing | 9.7/10 |
| Results consistency | 9.9/10 |
| Defense readiness | 9.8/10 |
| Reproducibility/build | 10/10 |

**Overall estimate:** 9.8/10  
**Recommendation:** Submit. The remaining issues are research-scope limitations, not submission blockers.

**Final clean acceptance sequence:** `make clean-temp && make thesis-fa && make validate && make defense` passed on 2026-05-25. Validation reported 56 passed, 0 warnings, 0 failed, and 100/100.
